Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, 622 West 168th Street, PH8-101, New York, NY 10023, USA.
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, 622 West 168th Street, PH8-101, New York, NY 10023, USA.
Clin Chest Med. 2023 Jun;44(2):335-346. doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.
The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.
2019 年冠状病毒病（COVID-19）大流行导致全球严重急性呼吸窘迫综合征（ARDS）病例增加，体外膜氧合（ECMO）的需求也相应增加。接受 ECMO 支持的 COVID-19 感染所致严重 ARDS 患者的预后仍在不断变化中。大量患者需要接受 ECMO 治疗，而 ECMO 技术在实施方面存在实际和伦理方面的限制，且 COVID-19 相关 ARDS 患者的 ECMO 支持时间延长，这些都暴露出组织和资源利用方面的局限性。从研究到实施的多个层面上的协调努力，促成了 ECMO 治疗方式的诸多创新。
